NCT03221400: PEN-866 in Patients With Advanced Solid Malignancies |
|
|
| Recruiting | 1/2 | 340 | US | PEN-866 Sodium, fluorouracil, 5-Fluorouracil, 5-FU, Folinic acid, Leucovorin, Niraparib, Zejula | Tarveda Therapeutics | Carcinoma, Endometrial Adenocarcinoma, Neoplasms, Squamous Cell Carcinoma of the Anus, Adenocarcinoma of the Pancreas, Advanced Cancer, Solid Tumor, Solid Carcinoma, Squamous Cell Carcinoma of the Cervix, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Vulva, Squamous Cell Carcinoma of the Penis, Gastric Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small-cell Lung Cancer, Small Cell Lung Carcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma | 01/23 | 06/23 | | |
NCT04890093: Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors |
|
|
| Not yet recruiting | 1/2 | 64 | US | PEN-866, Vincristine, Temozolomide | National Cancer Institute (NCI) | Sarcoma, Ewing, Rhabdomyosarcoma | 02/26 | 12/26 | | |
